SEARCH RESULTS

Results for "Equity Markets"

245. Randy Cohen, Senior Lecturer at Harvard Business School – Dangerous Vision in Stock Markets and Venture Capital

Randy Cohen, is a Senior Lecturer at Harvard Business school.  His main research focus is the interface between the actions of institutional investors and price levels in the stock market and has helped to start and grow a number of investment management firms.  He is a partner at Exsight Capital, a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. This has particular resonance for Randy, who is blind from retinitis pigmentosa.

Episode 226: Katie Stitch: Primary Thoughts on Secondary Markets

Katie Stitch is a partner at W Capital Partners, a private equity firm based in the NYC area that provides secondary liquidity solutions to private company shareholders and to PE/VC investment firms. She has held a number of Board roles and started her career as an analyst in investment banking.

196. Duncan MacInnes of Ruffer: The art of MiniMax Regret and Portfolio Construction in Today’s Markets

Duncan McInnes is an Investment Director at Ruffer LLP, where he has spent over a decade. He previously worked in wealth management. I have enjoyed listening to Duncan discuss positioning and multi-asset insights on the conference circuit and wanted to take this opportunity to discuss his views on the current macro backdrop as well as the state of play in finance circles as we wrestle with failing banks and what this means for investors.

18. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa

Shalom Lloyd,  after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020. 

Series 3 of 2025 – Trailer – The Gutsy Advocates who Run their own Race

We are delighted to bring you Series 3 of our 2025 series, which we again are launching amid significant volatility in markets. However, as you will hear, the more things change, the more they stay the same. We start this series down under, hearing from Debby Blakey, CEO of Hesta, who describes what it means to be a “Super with Impact”, and a gutsy advocate for a fair and healthy community. 

311. Dan Gore of Orthogonal Partners: Approaching Investing from all of the Right Angles

Daniel Gore is a Founding Partner of Orthogonal Partners, a boutique asset manager investing in “next generation” alternative investment strategies. He has had an extensive career in investing, including time spent in angel investing, in a family office and in film finance. He is currently pursuing opportunities in small and mid market UK firms.